We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$529M
AUM Growth
+$11.6M
Cap. Flow
+$6.55M
Cap. Flow %
1.24%
Top 10 Hldgs %
37.11%
Holding
121
New
7
Increased
37
Reduced
54
Closed
7

Top Buys

Rank Stock Value
1
EVRG icon
Evergy
EVRG
+$8.87M
2
HAL icon
Halliburton
HAL
+$3.68M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.95M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.25M
5
ACM icon
Aecom
ACM
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 23.68%
2 Industrials 19.93%
3 Technology 18.48%
4 Energy 11.09%
5 Utilities 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
76
Phillips 66
PSX
$84.4B
$521K 0.1%
4,637
+52
+1% +$5.85K
DHR icon
77
Danaher
DHR
$138B
$514K 0.1%
5,880
BLK icon
78
Blackrock
BLK
$170B
$505K 0.1%
1,011
+11
+1% +$5.81K
LH icon
79
Labcorp
LH
$25.9B
$501K 0.09%
3,250
MU icon
80
Micron Technology
MU
$988B
$456K 0.09%
8,700
PEP icon
81
PepsiCo
PEP
$191B
$449K 0.08%
4,125
+82
+2% +$8.47K
RDS.A
82
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$432K 0.08%
6,243
JCI icon
83
Johnson Controls International
JCI
$87.8B
$429K 0.08%
12,816
+5,135
+67% +$178K
T icon
84
AT&T
T
$159B
$429K 0.08%
17,678
+3,890
+28% +$97.6K
APH icon
85
Amphenol
APH
$197B
$427K 0.08%
+19,600
New +$427K
CELG
86
DELISTED
Celgene Corp
CELG
$414K 0.08%
5,208
+1,200
+30% +$99.6K
CI icon
87
Cigna
CI
$76.1B
$408K 0.08%
2,400
TSM icon
88
TSMC
TSM
$2.09T
$388K 0.07%
10,600
GM icon
89
General Motors
GM
$80B
$384K 0.07%
9,750
-700
-7% -$27.6K
DIS icon
90
Walt Disney
DIS
$167B
$383K 0.07%
3,656
KO icon
91
Coca-Cola
KO
$381B
$364K 0.07%
8,306
-400
-5% -$17.3K
IQV icon
92
IQVIA
IQV
$39.1B
$359K 0.07%
3,600
BKR icon
93
Baker Hughes
BKR
$59.5B
$344K 0.07%
+10,400
New +$353K
OCLR
94
DELISTED
Oclaro Inc.
OCLR
$332K 0.06%
37,200
+5,300
+17% +$46.4K
LLY icon
95
Eli Lilly
LLY
$1.03T
$320K 0.06%
3,751
+1,000
+36% +$82.1K
REGN icon
96
Regeneron Pharmaceuticals
REGN
$77.4B
$310K 0.06%
900
COHR icon
97
Coherent
COHR
$48.7B
$304K 0.06%
7,000
+200
+3% +$8.83K
SHW icon
98
Sherwin-Williams
SHW
$83.7B
$298K 0.06%
2,193
-300
-12% -$38.8K
QQQ icon
99
Invesco QQQ Trust
QQQ
$450B
$279K 0.05%
1,624
EEM icon
100
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$277K 0.05%
6,400
+900
+16% +$41.7K

Similar funds

John G. Ullman & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, John G. Ullman & Associates held 121 positions worth $529M, up 2.2% from $517M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

John G. Ullman & Associates's Q2 2018 filing shows 7 new, 37 increased, 54 reduced and 7 closed positions. Its largest new stake was Evergy: 165,574 shares worth $9.3M. The largest sale was Great Plains Energy Incorporated, an estimated $8.99M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q2 2018 buy was Evergy: 165,574 shares worth $9.3M.
  • John G. Ullman & Associates added most to Halliburton in Q2 2018, an estimated $3.68M increase.
  • John G. Ullman & Associates's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $1.24M.
  • John G. Ullman & Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $8.99M.
  • John G. Ullman & Associates's ten largest holdings make up 37% of its $529M portfolio in Q2 2018.
  • John G. Ullman & Associates opened 7 new positions and closed 7 in Q2 2018.
  • John G. Ullman & Associates's portfolio value rose 2.2% quarter-over-quarter to $529M.

Based on John G. Ullman & Associates's 13F filing for Q2 2018, filed 23 Jul 2018.